Targeting toll-like receptors for treatment of SLE

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Farris, A Darise ^a,b   Horton, Christopher G ^a,b   Pan, Zi Jian ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; GALACTOSAMINE; INTERFERON; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DNA DETERMINATION; DNA SEQUENCE; DRUG TARGETING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLOMERULONEPHRITIS; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNE DISEASES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MODELS, BIOLOGICAL; TOLL-LIKE RECEPTORS;

EID: 77957899771     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/498980     Document Type: Review

References (97)

1. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity Cell 2006 124 4 783 801
2. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S., Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway Science 2003 301 5633 640 643 (Pubitemid 36927946)
3. Kawai T., Akira S., TLR signaling Seminars in Immunology 2007 19 1 24 32
4. Hoebe K., Janssen E., Beutler B., The interface between innate and adaptive immunity Nature Immunology 2004 5 10 971 974
5. Akira S., Takeda K., Kaisho T., Toll-like receptors: critical proteins linking innate and acquired immunity Nature Immunology 2001 2 8 675 680 (Pubitemid 32747155)
6. Park Y., Park S., Yoo E., Kim D., Shin H., Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility Annals of the New York Academy of Sciences 2004 1037 170 174
7. Devaraj S., Dasu M. R., Rockwood J., Winter W., Griffen S. C., Jialal I., Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state Journal of Clinical Endocrinology and Metabolism 2008 93 2 578 583
8. Kim H. S., Han M. S., Chung K. W., Kim S., Kim E., Kim M. J., Jang E., Lee H. A., Youn J., Akira S., Lee M.-S., Toll-like receptor 2 senses -cell death and contributes to the initiation of autoimmune diabetes Immunity 2007 27 2 321 333
9. Mohammad M. K., Morran M., Slotterbeck B., Leaman D. W., Sun Y., von Grafenstein H., Hong S.-C., McInerney M. F., Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse International Immunology 2006 18 7 1101 1113
10. Roelofs M. F., Wenink M. H., Brentano F., Abdollahi-Roodsaz S., Oppers-Walgreen B., Barrera P., Van Riel P. L. C. M., Joosten L. A. B., Kyburz D., Van Den Berg W. B., Radstake T. R. D. J., Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA) Annals of the Rheumatic Diseases 2009 68 9 1486 1493
11. Maciejewska Rodrigues H., Jngel A., Gay R. E., Gay S., Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis Molecular Immunology 2009 47 1 12 18
12. Anders H.-J., A toll for lupus Lupus 2005 14 6 417 422
13. Christensen S. R., Kashgarian M., Alexopoulou L., Flavell R. A., Akira S., Shlomchik M. J., Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus Journal of Experimental Medicine 2005 202 2 321 331
14. Christensen S. R., Shupe J., Nickerson K., Kashgarian M., Flavell R., Shlomchik M. J., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus Immunity 2006 25 3 417 428
15. Lafyatis R., Marshak-Rothstein A., Toll-like receptors and innate immune responses in systemic lupus erythematosus Arthritis Research and Therapy 2007 9 6, article 222
16. Subramanian S., Tus K., Li Q.-Z., Wang A., Tian X.-H., Zhou J., Liang C., Bartov G., McDaniel L. D., Zhou X. J., Schultz R. A., Wakeland E. K., A Tlr7 translocation accelerates systemic autoimmunity in murine lupus Proceedings of the National Academy of Sciences of the United States of America 2006 103 26 9970 9975
17. Pisitkun P., Deane J. A., Difilippantonio M. J., Tarasenko T., Satterthwaite A. B., Bolland S., Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication Science 2006 312 5780 1669 1672
18. Weeratna R. D., Makinen S. R., McCluskie M. J., Davis H. L., TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848) Vaccine 2005 23 45 5263 5270
19. Lahiri A., Das P., Chakravortty D., Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond Vaccine 2008 26 52 6777 6783
20. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A., Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells European Journal of Immunology 2001 31 11 3388 3393
21. Kadowaki N., Ho S., Antonenko S., De Waal Malefyt R., Kastelein R. A., Bazan F., Liu Y.-J., Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens Journal of Experimental Medicine 2001 194 6 863 869
22. Dorner M., Brandt S., Tinguely M., Zucol F., Bourquin J.-P., Zauner L., Berger C., Bernasconi M., Speck R. F., Nadal D., Plasma cell Toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production Immunology 2009 128 4 573 579
23. Takeda K., Kaisho T., Akira S., Toll-like receptors Annual Review of Immunology 2003 21 335 376
24. O'Neill L. A. J., Bowie A. G., The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling Nature Reviews Immunology 2007 7 5 353 364
25. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A., The human toll signaling pathway: divergence of nuclear factor b and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) Journal of Experimental Medicine 1998 187 12 2097 2101
26. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C. A. Jr., MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Molecular Cell 1998 2 2 253 258
27. Barton G. M., Medzhitov R., Toll-like receptor signaling pathways Science 2003 300 5625 1524 1525
28. Kawai T., Akira S., Toll-like receptor and RIG-1-like receptor signaling Annals of the New York Academy of Sciences 2008 1143 1 20
29. Markin C. J., Saltibus L. F., Spyracopoulos L., Dynamics of the RING domain from human TRAF6 by 15N NMR spectroscopy: implications for biological function Biochemistry 2008 47 38 10010 10017
30. Kawai T., Sato S., Ishii K. J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J.-I., Uematsu S., Takeuchi O., Akira S., Interferon- induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 Nature Immunology 2004 5 10 1061 1068
31. Silverman N., Maniatis T., NF- B signaling pathways in mammalian and insect innate immunity Genes and Development 2001 15 18 2321 2342
32. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N., IRF family of transcription factors as regulators of host defense Annual Review of Immunology 2001 19 623 655
33. Colonna M., TLR pathways and IFN-regulatory factors: to each its own European Journal of Immunology 2007 37 2 306 309
34. Honda K., Yanai H., Mizutani T., Negishi H., Shimada N., Suzuki N., Ohba Y., Takaoka A., Yeh W.-C., Taniguchi T., Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling Proceedings of the National Academy of Sciences of the United States of America 2004 101 43 15416 15421
35. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T., IRF-7 is the master regulator of type-I interferon-dependent immune responses Nature 2005 434 7034 772 777
36. Yasuda K., Richez C., Maciaszek J. W., Agrawal N., Akira S., Marshak-Rothstein A., Rifkin I. R., Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production Journal of Immunology 2007 178 11 6876 6885
37. McWhirter S. M., Fitzgerald K. A., Rosains J., Rowe D. C., Golenbock D. T., Maniatis T., IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts Proceedings of the National Academy of Sciences of the United States of America 2004 101 1 233 238
38. Chuang T.-H., Ulevitch R. J., Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors Nature Immunology 2004 5 5 495 502
39. Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., Tschopp J., Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 Journal of Experimental Medicine 2003 197 2 263 268
40. Janssens S., Burns K., Vercammen E., Tschopp J., Beyaert R., MyD88S, a splice variant of MyD88, differentially modulates NF- B- and AP-1-dependent gene expression FEBS Letters 2003 548 13 103 107
41. An H., Hou J., Zhou J., Zhao W., Xu H., Zheng Y., Yu Y., Liu S., Cao X., Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1 Nature Immunology 2008 9 5 542 550
42. Kobayashi K., Hernandez L. D., Galn J. E., Janeway C. A. Jr., Medzhitov R., Flavell R. A., IRAK-M is a negative regulator of Toll-like receptor signaling Cell 2002 110 2 191 202
43. Rao N., Nguyen S., Ngo K., Fung-Leung W.-P., A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling Molecular and Cellular Biology 2005 25 15 6521 6532
44. Boone D. L., Turer E. E., Lee E. G., Ahmad R.-C., Wheeler M. T., Tsui C., Hurley P., Chien M., Chai S., Hitotsumatsu O., McNally E., Pickart C., Ma A., The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses Nature Immunology 2004 5 10 1052 1060
45. Negishi H., Ohba Y., Yanai H., Takaoka A., Honma K., Yui K., Matsuyama T., Taniguchi T., Honda K., Negative regulation of Toll-like-receptor signaling by IRF-4 Proceedings of the National Academy of Sciences of the United States of America 2005 102 44 15989 15994
46. Christensen S. R., Shlomchik M. J., Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors Seminars in Immunology 2007 19 1 11 23
47. Savarese E., Steinberg C., Pawar R. D., Reindl W., Akira S., Anders H.-J., Krug A., Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis Arthritis and Rheumatism 2008 58 4 1107 1115
48. Blossom S., Chu E. B., Weigle W. O., Gilbert K. M., CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus Journal of Immunology 1997 159 9 4580 4586
49. Merino R., Fossati L., Izui S., The lupus-prone BXSB strain: the Yaa gene model of systemic lupus erythematosus Springer Seminars in Immunopathology 1992 14 2 141 157
50. Bolland S., Yim Y.-S., Tus K., Wakeland E. K., Ravetch J. V., Genetic modifiers of systemic lupus erythematosus in Fc RIIB-/-mice Journal of Experimental Medicine 2002 195 9 1167 1174
51. Kono D. H., Haraldsson M. K., Lawson B. R., Pollard K. M., Yi T. K., Du X., Arnold C. N., Baccala R., Silverman G. J., Beutler B. A., Theofilopoulos A. N., Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus Proceedings of the National Academy of Sciences of the United States of America 2009 106 29 12061 12066
52. Herrmann M., Voll R. E., Zoller O. M., Hagenhofer M., Ponner B. B., Kalden J. R., Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus Arthritis and Rheumatism 1998 41 7 1241 1250
53. Steinman C. R., Circulating DNA in systemic lupus erythematosus. Isolation and characterization Journal of Clinical Investigation 1984 73 3 832 841
54. Amoura Z., Piette J.-C., Chabre H., Cacoub P., Papo T., Wechsler B., Bach J.-F., Koutouzov S., Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus Arthritis and Rheumatism 1997 40 12 2217 2225
55. Pan Z.-J., Maier S., Schwarz K., Azbill J., Akira S., Uematsu S., Farris A. D., Toll-like receptor 7 (TLR7) modulates anti-nucleosomal autoantibody isotype and renal complement deposition in mice exposed to syngeneic late apoptotic cells Annals of the Rheumatic Diseases 2010 69 6 1195 1199
56. Wu X., Peng S. L., Toll-like receptor 9 signaling protects against murine lupus Arthritis and Rheumatism 2006 54 1 336 342
57. Lartigue A., Courville P., Auquit I., Franois A., Arnoult C., Tron F., Gilbert D., Musette P., Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced marine lupus Journal of Immunology 2006 177 2 1349 1354
58. Yu P., Wellmann U., Kunder S., Quintanilla-Martinez L., Jennen L., Dear N., Amann K., Bauer S., Winkler T. H., Wagner H., Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE International Immunology 2006 18 8 1211 1219
59. Patole P. S., Grne H.-J., Segerer S., Ciubar R., Belemezova E., Henger A., Kretzler M., Schlndorff D., Anders H.-J., Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells Journal of the American Society of Nephrology 2005 16 5 1326 1338
60. Bennett L., Palucka A. K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V., Interferon and granulopoiesis signatures in systemic lupus erythematosus blood Journal of Experimental Medicine 2003 197 6 711 723
61. Ytterberg S. R., Schnitzer T. J., Serum interferon levels in patients with systemic lupus erythematosus Arthritis and Rheumatism 1982 25 4 401 406
62. Ioannou Y., Isenberg D. A., Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy Arthritis and Rheumatism 2000 43 7 1431 1442
63. Visentini M., Conti V., Cagliuso M., Tinti F., Siciliano G., Trombetta A. C., Mitterhofer A. P., Fiorilli M., Quinti I., Regression of systemic lupus erythematosus after development of an acquired Toll-like receptor signaling defect and antibody deficiency Arthritis and Rheumatism 2009 60 9 2767 2771
64. De Jager P. L., Richardson A., Vyse T. J., Rioux J. D., Genetic variation in Toll-like receptor 9 and susceptibility to systemic lupus erythematosus Arthritis and Rheumatism 2006 54 4 1279 1282 (Pubitemid 43672940)
65. Hur J.-W., Shin H. D., Park B. L., Kim L. H., Kim S.-Y., Bae S.-C., Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus Tissue Antigens 2005 65 3 266 270
66. Demirci F. Y. K., Manzi S., Ramsey-Goldman R., Kenney M., Shaw P. S., Dunlop-Thomas C. M., Kao A. H., Rhew E. Y., Bontempo F., Kammerer C., Kamboh M. I., Association study of Toll-like Receptor 5 (TLR5) and Toll-like Receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus Journal of Rheumatology 2007 34 8 1708 1711
67. Ng M. W., Lau C. S., Chan T. M., Wong W. H. S., Lau Y. L., Polymorphisms of the Toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese Rheumatology 2005 44 11 1456 1457
68. Migita K., Miyashita T., Maeda Y., Nakamura M., Yatsuhashi H., Kimura H., Ishibashi H., Eguchi K., Toll-like receptor expression in lupus peripheral blood mononuclear cells Journal of Rheumatology 2007 34 3 493 500
69. Nakano S., Morimoto S., Suzuki J., Nozawa K., Amano H., Tokano Y., Takasaki Y., Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus Rheumatology 2008 47 2 145 149
70. Papadimitraki E. D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., Raptopoulou A., Kritikos H. D., Mamalaki C., Sidiropoulos P., Boumpas D. T., Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process Arthritis and Rheumatism 2006 54 11 3601 3611
71. Moser K. L., Kelly J. A., Lessard C. J., Harley J. B., Recent insights into the genetic basis of systemic lupus erythematosus Genes and Immunity 2009 10 5 373 379
72. Bates J. S., Lessard C. J., Leon J. M., Nguyen T., Battiest L. J., Rodgers J., Kaufman K. M., James J. A., Gilkeson G. S., Kelly J. A., Humphrey M. B., Harley J. B., Gray-McGuire C., Moser K. L., Gaffney P. M., Meta-analysis and imputation identifies a 109kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations Genes and Immunity 2009 10 5 470 477
73. Graham R. R., Cotsapas C., Davies L., Hackett R., Lessard C. J., Leon J. M., Burtt N. P., Guiducci C., Parkin M., Gates C., Plenge R. M., Behrens T. W., Wither J. E., Rioux J. D., Fortin P. R., Cunninghame Graham D., Wong A. K., Vyse T. J., Daly M. J., Altshuler D., Moser K. L., Gaffney P. M., Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus Nature Genetics 2008 40 9 1059 1061
74. Musone S. L., Taylor K. E., Lu T. T., Nititham J., Ferreira R. C., Ortmann W., Shifrin N., Petri M. A., Ilyas Kamboh M., Manzi S., Seldin M. F., Gregersen P. K., Behrens T. W., Ma A., Kwok P.-Y., Criswell L. A., Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus Nature Genetics 2008 40 9 1062 1064
75. Komatsuda A., Wakui H., Iwamoto K., Ozawa M., Togashi M., Masai R., Maki N., Hatakeyama T., Sawada K., Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus Clinical and Experimental Immunology 2008 152 3 482 487
76. Lartigue A., Colliou N., Calbo S., Frans A., Jacquot S., Arnoult C., Tron F., Gilbert D., Musette P., Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus Journal of Immunology 2009 183 10 6207 6216
77. Barrat F. J., Meeker T., Gregorio J., Chan J. H., Uematsu S., Akira S., Chang B., Duramad O., Coffman R. L., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus Journal of Experimental Medicine 2005 202 8 1131 1139
78. Duramad O., Fearon K. L., Chang B., Chan J. H., Gregorio J., Coffman R. L., Barrat F. J., Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation Journal of Immunology 2005 174 9 5193 5200
79. Rozzo S. J., Allard J. D., Choubey D., Vyse T. J., Izui S., Peltz G., Kotzin B. L., Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus Immunity 2001 15 3 435 443
80. Santiago-Raber M.-L., Baccala R., Haraldsson K. M., Choubey D., Stewart T. A., Kono D. H., Theofilopoulos A. N., Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice Journal of Experimental Medicine 2003 197 6 777 788
81. Crow M. K., Type I interferon in systemic lupus erythematosus Current Topics in Microbiology and Immunology 2007 316 359 386
82. Barrat F. J., Meeker T., Chan J. H., Guiducci C., Coffmann R. L., Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms European Journal of Immunology 2007 37 12 3582 3586
83. Dong L., Ito S., Ishii K. J., Klinman D. M., Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice Arthritis and Rheumatism 2005 52 2 651 658
84. Pawar R. D., Ramanjaneyulu A., Kulkarni O. P., Lech M., Segerer S., Anders H.-J., Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus Journal of the American Society of Nephrology 2007 18 6 1721 1731
85. Oda K., Kitano H., A comprehensive map of the Toll-like receptor signaling network Molecular Systems Biology 2006 2
86. Bartfai T., Behrens M. M., Gaidarova S., Pemberton J., Shivanyuk A., Rebek J. Jr., A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 7971 7976
87. Loiarro M., Sette C., Gallo G., Ciacci A., Fant N., Mastroianni D., Carminati P., Ruggiero V., Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF- B Journal of Biological Chemistry 2005 280 16 15809 15814
88. Loiarro M., Capolunghi F., Fant N., Gallo G., Campo S., Arseni B., Carsetti R., Carminati P., De Santis R., Ruggiero V., Sette C., Pivotal Advance: inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound Journal of Leukocyte Biology 2007 82 4 801 810
89. Suzuki N., Suzuki S., Duncan G. S., Millar D. G., Wada T., Mirtsos C., Takada H., Wakeham A., Itie A., Li S., Penninger J. M., Wesche H., Ohashi P. S., Mak T. W., Yeh W.-C., Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 Nature 2002 416 6882 750 754
90. Tae W. K., Staschke K., Bulek K., Yao J., Peters K., Oh K.-H., Vandenburg Y., Xiao H., Qian W., Hamilton T., Min B., Sen G., Gilmour R., Li X., A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity Journal of Experimental Medicine 2007 204 5 1025 1036
91. Buckley G. M., Fosbeary R., Fraser J. L., Gowers L., Higueruelo A. P., James L. A., Jenkins K., Mack S. R., Morgan T., Parry D. M., Pitt W. R., Rausch O., Richard M. D., Sabin V., IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridines Bioorganic and Medicinal Chemistry Letters 2008 18 12 3656 3660
92. Wang Z., Liu J., Sudom A., Ayres M., Li S., Wesche H., Powers J. P., Walker N. P. C., Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper Structure 2006 14 12 1835 1844
93. Powers J. P., Li S., Jaen J. C., Liu J., Walker N. P. C., Wang Z., Wesche H., Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4 Bioorganic and Medicinal Chemistry Letters 2006 16 11 2842 2845
94. Cohen P., Targeting protein kinases for the development of anti-inflammatory drugs Current Opinion in Cell Biology 2009 21 2 317 324
95. Rnnblom L., Pascual V., The innate immune system in SLE: type I interferons and dendritic cells Lupus 2008 17 5 394 399
96. Guiducci C., Coffman R. L., Barrat F. J., Signalling pathways leading to IFN- production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications Journal of Internal Medicine 2009 265 1 43 57
97. Xie Q., Gan L., Wang J., Wilson I., Li L., Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth Molecular Immunology 2007 44 14 3453 3461